Handbook of Adaptive Designs in Pharmaceutical and Clinical Development
Herausgeber: Pong, Annpey; Chow, Shein-Chung
Handbook of Adaptive Designs in Pharmaceutical and Clinical Development
Herausgeber: Pong, Annpey; Chow, Shein-Chung
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This handbook provides a comprehensive and unified presentation of the principles and latest statistical methodologies used when modifying trial procedures based on accrued data of ongoing clinical trials. The book also gives a well-balanced summary of current regulatory perspectives and presents real-world examples of a range of adaptive design
Andere Kunden interessierten sich auch für
- Richard ChinAdaptive and Flexible Clinical Trials92,99 €
- Mark ChangInnovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials68,99 €
- Alessandro Baldi AntogniniAdaptive Designs for Sequential Treatment Allocation92,99 €
- Platform Trial Designs in Drug Development68,99 €
- Advanced Statistics in Regulatory Critical Clinical Initiatives76,99 €
- S W BergmanStatistical Methods for Pharmaceutical Research Planning85,99 €
- Jay HersonData and Safety Monitoring Committees in Clinical Trials68,99 €
-
-
-
This handbook provides a comprehensive and unified presentation of the principles and latest statistical methodologies used when modifying trial procedures based on accrued data of ongoing clinical trials. The book also gives a well-balanced summary of current regulatory perspectives and presents real-world examples of a range of adaptive design
Produktdetails
- Produktdetails
- Verlag: CRC Press
- Seitenzahl: 496
- Erscheinungstermin: 30. Juni 2020
- Englisch
- Abmessung: 254mm x 178mm x 25mm
- Gewicht: 853g
- ISBN-13: 9780367577117
- ISBN-10: 0367577119
- Artikelnr.: 69892902
- Verlag: CRC Press
- Seitenzahl: 496
- Erscheinungstermin: 30. Juni 2020
- Englisch
- Abmessung: 254mm x 178mm x 25mm
- Gewicht: 853g
- ISBN-13: 9780367577117
- ISBN-10: 0367577119
- Artikelnr.: 69892902
Annpey Pong is a manager in the Department of Biostatistics and Research Decision Sciences at Merck Research Laboratories. Dr. Pong is also the associate editor of the Journal of Biopharmaceutical Statistics. She earned her Ph.D. in statistics from Temple University. Shein-Chung Chow is a professor in the Department of Biostatistics and Bioinformatics at Duke University School of Medicine. Dr. Chow is also a professor of clinical sciences at Duke-National University of Singapore Graduate Medical School and the editor of the Journal of Biopharmaceutical Statistics. He earned his Ph.D. in statistics from the University of Wisconsin-Madison.
Overview of Adaptive Design Methods in Clinical Trials. Fundamental Theory
of Adaptive Designs with Unplanned Design Change in Clinical Trials with
Blinded Data. Bayesian Approach for Adaptive Design. The Impact of Protocol
Amendments in Adaptive Trial Designs. From Group Sequential to Adaptive
Designs. Determining Sample Size for Classical Designs. Sample Size
Reestimation Design with Applications in Clinical Trials. Adaptive Interim
Analyses in Clinical Trials. Classical Dose-Finding Trial. Improving
Dose-Finding: A Philosophic View. Adaptive Dose-Ranging Studies. Seamless
Phase I/II Designs. Phase II/III Seamless Designs. Sample Size
Estimation/Allocation for Two-Stage Seamless Adaptive Trial Designs.
Optimal Response-Adaptive Randomization for Clinical Trials.
Hypothesis-Adaptive Design. Treatment Adaptive Allocations in Randomized
Clinical Trials: An Overview. Integration of Predictive Biomarker
Diagnostics into Clinical Trials for New Drug Development. Clinical
Strategy for Study Endpoint Selection. Adaptive Infrastructure. Independent
Data Monitoring Committees. Targeted Clinical Trials. Functional
Genome-Wide Association Studies of Longitudinal Traits. Adaptive Trial
Simulation. Efficiency of Adaptive Designs. Cases Studies in Adaptive
Design. Good Practices for Adaptive Clinical Trials. Index.
of Adaptive Designs with Unplanned Design Change in Clinical Trials with
Blinded Data. Bayesian Approach for Adaptive Design. The Impact of Protocol
Amendments in Adaptive Trial Designs. From Group Sequential to Adaptive
Designs. Determining Sample Size for Classical Designs. Sample Size
Reestimation Design with Applications in Clinical Trials. Adaptive Interim
Analyses in Clinical Trials. Classical Dose-Finding Trial. Improving
Dose-Finding: A Philosophic View. Adaptive Dose-Ranging Studies. Seamless
Phase I/II Designs. Phase II/III Seamless Designs. Sample Size
Estimation/Allocation for Two-Stage Seamless Adaptive Trial Designs.
Optimal Response-Adaptive Randomization for Clinical Trials.
Hypothesis-Adaptive Design. Treatment Adaptive Allocations in Randomized
Clinical Trials: An Overview. Integration of Predictive Biomarker
Diagnostics into Clinical Trials for New Drug Development. Clinical
Strategy for Study Endpoint Selection. Adaptive Infrastructure. Independent
Data Monitoring Committees. Targeted Clinical Trials. Functional
Genome-Wide Association Studies of Longitudinal Traits. Adaptive Trial
Simulation. Efficiency of Adaptive Designs. Cases Studies in Adaptive
Design. Good Practices for Adaptive Clinical Trials. Index.
Overview of Adaptive Design Methods in Clinical Trials. Fundamental Theory
of Adaptive Designs with Unplanned Design Change in Clinical Trials with
Blinded Data. Bayesian Approach for Adaptive Design. The Impact of Protocol
Amendments in Adaptive Trial Designs. From Group Sequential to Adaptive
Designs. Determining Sample Size for Classical Designs. Sample Size
Reestimation Design with Applications in Clinical Trials. Adaptive Interim
Analyses in Clinical Trials. Classical Dose-Finding Trial. Improving
Dose-Finding: A Philosophic View. Adaptive Dose-Ranging Studies. Seamless
Phase I/II Designs. Phase II/III Seamless Designs. Sample Size
Estimation/Allocation for Two-Stage Seamless Adaptive Trial Designs.
Optimal Response-Adaptive Randomization for Clinical Trials.
Hypothesis-Adaptive Design. Treatment Adaptive Allocations in Randomized
Clinical Trials: An Overview. Integration of Predictive Biomarker
Diagnostics into Clinical Trials for New Drug Development. Clinical
Strategy for Study Endpoint Selection. Adaptive Infrastructure. Independent
Data Monitoring Committees. Targeted Clinical Trials. Functional
Genome-Wide Association Studies of Longitudinal Traits. Adaptive Trial
Simulation. Efficiency of Adaptive Designs. Cases Studies in Adaptive
Design. Good Practices for Adaptive Clinical Trials. Index.
of Adaptive Designs with Unplanned Design Change in Clinical Trials with
Blinded Data. Bayesian Approach for Adaptive Design. The Impact of Protocol
Amendments in Adaptive Trial Designs. From Group Sequential to Adaptive
Designs. Determining Sample Size for Classical Designs. Sample Size
Reestimation Design with Applications in Clinical Trials. Adaptive Interim
Analyses in Clinical Trials. Classical Dose-Finding Trial. Improving
Dose-Finding: A Philosophic View. Adaptive Dose-Ranging Studies. Seamless
Phase I/II Designs. Phase II/III Seamless Designs. Sample Size
Estimation/Allocation for Two-Stage Seamless Adaptive Trial Designs.
Optimal Response-Adaptive Randomization for Clinical Trials.
Hypothesis-Adaptive Design. Treatment Adaptive Allocations in Randomized
Clinical Trials: An Overview. Integration of Predictive Biomarker
Diagnostics into Clinical Trials for New Drug Development. Clinical
Strategy for Study Endpoint Selection. Adaptive Infrastructure. Independent
Data Monitoring Committees. Targeted Clinical Trials. Functional
Genome-Wide Association Studies of Longitudinal Traits. Adaptive Trial
Simulation. Efficiency of Adaptive Designs. Cases Studies in Adaptive
Design. Good Practices for Adaptive Clinical Trials. Index.